Governance BIGN HLDG

BTH

AU000000BTH6

Market Closed - Australian S.E. Other stock markets 07:10:14 10/09/2024 BST			5-day change	1st Jan Change
0.1050 ^AUD	-4.55%		-16.00%	-47.50%

08-29	Transcript : Bigtincan Holdings Limited, 2024 Earnings Call, Aug 29, 2024
08-29	Bigtincan Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2024	CI

Executive Committee: BIGN HLDG

Manager

Positions heldSince

David Keane

Chief Executive Officer	31/12/2010
Founder	31/12/2010

Patrick Welch

President	-
Sales & Marketing	31/12/2011

Vivian Stewart

Chief Operating Officer

04/04/2018

Lucy Rowe

48 year

Corporate Secretary

02/06/2024

Cyril Desouza

Comptroller/Controller/Auditor

Composition of the Board of Directors: BIGN HLDG

Director

CommitteesSince

Thomas Amos

Audit Committee
Compensation Committee	27/09/2016
Nominating Committee	27/09/2016
Audit Committee Chair

Inese Kingsmill

Audit Committee
Compensation Committee	05/10/2021
Nominating Committee	05/10/2021
Finance Committee
Compensation Committee Chair
Nominating Committee Chair

Wayne Stevenson

Audit Committee Chair
Audit Committee	09/04/2015
Compensation Committee	27/09/2016
Governance Committee	09/04/2015
Nominating Committee	27/09/2016

Timothy Ebbeck

Audit Committee	07/03/2019
Compensation Committee Chair	07/03/2019
Nominating Committee Chair	07/03/2019

David Keane

Director/Board Member

31/12/2010

Latest Appointments: BIGN HLDG

Bigtincan Holdings Limited Announces Executive Changes	06-03	CI
Bigtincan Holdings Limited Announces Resignation of Farouk Hussein as Non-Executive Director	03/10/23	CI
Bigtincan Holdings Limited Announces Retirement of John Scull as Director	21/10/21	CI
Bigtincan Holdings Limited Appoints Two Non-Executive Directors	06/10/21	CI
Bigtincan Announces Executive Changes	03/05/18	CI
Bigtincan Announces Executive Changes	04/04/18	CI
Bigtincan Announces Death of Geoffrey P Cohen, Cofounder and Director	05/12/17	CI

More news

Former Officers and Directors: BIGN HLDG

Insider

Positions held

SinceUntil

Mark Ohlsson

Investor Relations Contact	-	02/06/2024
Corporate Secretary	31/12/2011	02/06/2024

Farouk Hussein

Director/Board Member

05/10/2021

02/10/2023

Rafi Mubarak

Corporate Officer/Principal

04/04/2018

31/07/2022

John Scull

Director/Board Member

31/12/2014

31/10/2021

Anthony Turco

Chief Tech/Sci/R&D Officer

31/05/2018

William A. Bartee

Director/Board Member

31/10/2013

30/11/2015

Geoffrey Cohen

Director/Board Member	31/12/2010	-
Director of Finance/CFO	31/12/2010	-
Founder	31/12/2010	-

Age distribution of managers

Parity Men Women

Male	9
Female	2

Of which Executive Committee

Male	4
Female	1

Of which Directors

Male	4
Female	1

ESG Refinitiv

Beta Pharmaceutical Limited is a Australia-based biopharmaceutical company. The Company is focused on the identification, development and commercialization of products and therapies targeting the chemoprevention and treatment of breast cancer. The Company is working in collaboration with scientists at the College of Pharmacy, University of Louisiana at Monroe in southern the United States of America (ULM) to develop cancer chemopreventive agents using natural phytonutrients, called tocotrienols as treatments for breast cancers. Funded by Beta Pharmaceutical Limited, the applied research programme with ULM includes four laboratories and is known as the Breast Cancer and Health Project, which has been underway.

Employees

495

Sector

More about the company

Governance BIGN HLDG

Equities

BTH

AU000000BTH6

Executive Committee: BIGN HLDG

Composition of the Board of Directors: BIGN HLDG

Latest Appointments: BIGN HLDG

Former Officers and Directors: BIGN HLDG

Age distribution of managers

Parity Men Women

Company Profile